Search

A potential new way to overcome fulvestrant resistance in secondary breast cancer

Scientists have furthered our understanding of how some secondary breast cancers can become resistant to the hormone therapy fulvestrant.

Leuprorelin (Prostap)

Leuprorelin, also known as Prostap, is a hormone therapy used to treat breast cancer in women who've not been through the menopause.

Walking saved me after I lost my mum

When Sacha lost her mum to breast cancer in 2019, she wanted to do something in her memory.

Paclitaxel (Taxol)

Learn about chemotherapy drug paclitaxel (Taxol), including when it's used and its side effects.

Overnight events

We respond to NICE provisional decision to not recommend elacestrant in England

Claire Rowney, chief executive at Breast Cancer Now, said:

Tests used for diagnosing and monitoring metastatic breast cancer with Catherine Bailey

Tuesday 12 May at 2pm, Webinar

Breast Cancer Now response to the death of Linda Nolan

Claire Rowney, CEO, Breast Cancer Now says:

We respond to publication of Scottish Referral Guidelines for Suspected Cancer

Melanie Sturtevant, associate director of policy, evidence and influencing at Breast Cancer Now, said:

Quiz nights

Reuben's story

After his breast cancer diagnosis, Reuben wants to do everything he can to raise awareness of male breast cancer.